228 related articles for article (PubMed ID: 24853905)
21. An exploratory panel of biomarkers for risk prediction in pulmonary hypertension: emerging role of CT-proET-1.
Silva Marques J; Martins SR; Calisto C; Gonçalves S; Almeida AG; de Sousa JC; Pinto FJ; Diogo AN
J Heart Lung Transplant; 2013 Dec; 32(12):1214-21. PubMed ID: 23916896
[TBL] [Abstract][Full Text] [Related]
22. Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI).
Baldenhofer G; Laule M; Mockel M; Sanad W; Knebel F; Dreger H; Leonhardt F; Sander M; Grubitzsch H; Baumann G; Stangl K; Stangl V
Clin Chem Lab Med; 2017 Feb; 55(2):275-283. PubMed ID: 27522619
[TBL] [Abstract][Full Text] [Related]
23. Precursors of adrenomedullin, endothelin and atrial natriuretic peptide as diagnostic markers of neonatal infection.
Cao Y; Xia Q; Chen C; Yang Y
Acta Paediatr; 2012 Mar; 101(3):242-6. PubMed ID: 22053979
[TBL] [Abstract][Full Text] [Related]
24. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
26. Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.
Frøssing S; Nylander M; Aziz M; Skouby SO; Kistorp C; Faber J
Gynecol Endocrinol; 2017 Jan; 33(1):30-33. PubMed ID: 27424881
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.
Sabatine MS; Morrow DA; de Lemos JA; Omland T; Sloan S; Jarolim P; Solomon SD; Pfeffer MA; Braunwald E
Circulation; 2012 Jan; 125(2):233-40. PubMed ID: 22179538
[TBL] [Abstract][Full Text] [Related]
28. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
[No Abstract] [Full Text] [Related]
29. Prognostic value of different biomarkers for cardiovascular death in unselected older patients in the emergency department.
Bahrmann P; Christ M; Hofner B; Bahrmann A; Achenbach S; Sieber CC; Bertsch T
Eur Heart J Acute Cardiovasc Care; 2016 Dec; 5(8):568-578. PubMed ID: 26483565
[TBL] [Abstract][Full Text] [Related]
30. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
31. Cord blood plasma reference intervals for potential sepsis markers: pro-adrenomedullin, pro-endothelin, and pro-atrial natriuretic peptide.
Miguel D; Prieto B; Costa M; Coto D; Alvarez FV
Clin Biochem; 2011 Mar; 44(4):337-41. PubMed ID: 21211519
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
[TBL] [Abstract][Full Text] [Related]
33. Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia.
Birdir C; Janssen K; Stanescu AD; Enekwe A; Kasimir-Bauer S; Gellhaus A; Kimmig R; Köninger A
Arch Gynecol Obstet; 2015 Nov; 292(5):1033-42. PubMed ID: 25975456
[TBL] [Abstract][Full Text] [Related]
34. The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea.
Wu AH; Tabas J; Stein J; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Nowak R; Peacock WF; Ponikowski P; Moeckel M; Hogan C; Filippatos GS; Di Somma S; Anand I; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
Biomarkers; 2012 Sep; 17(6):490-7. PubMed ID: 22616939
[TBL] [Abstract][Full Text] [Related]
35. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
Düngen HD; Tscholl V; Obradovic D; Radenovic S; Matic D; Musial Bright L; Tahirovic E; Marx A; Inkrot S; Hashemi D; Veskovic J; Apostolovic S; von Haehling S; Doehner W; Cvetinovic N; Lainscak M; Pieske B; Edelmann F; Trippel T; Loncar G
ESC Heart Fail; 2018 Apr; 5(2):288-296. PubMed ID: 29476612
[TBL] [Abstract][Full Text] [Related]
36. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
[TBL] [Abstract][Full Text] [Related]
37. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
Heining L; Giesa C; Ewig S
Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
[TBL] [Abstract][Full Text] [Related]
38. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts?
Kaiser R; Abdul-Khaliq H; Wilkens H; Herrmann E; Raedle-Hurst TM
Eur J Heart Fail; 2014 Oct; 16(10):1082-8. PubMed ID: 25201135
[TBL] [Abstract][Full Text] [Related]
39. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants.
Grass B; Baumann P; Arlettaz R; Fouzas S; Meyer P; Spanaus K; Wellmann S
Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
